Overview: Manganese TestIntroduction: The Manganese Test measures manganese in blood to diagnose toxicity, causing neurological symptoms. Following 2023 CDC guidelines, it uses toxicology methods for high specificity, supporting toxicity screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in toxicology for patients with suspected manganese exposure, particularly in occupational or environmental settings.
Other Names: Manganese Blood Assay, Blood Manganese Test.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic accuracy.
Historical Milestone: Blood manganese testing began in the 1980s with occupational health research. Analytical methods improved in the 2000s, enhancing detection sensitivity.
Purpose: Measures manganese in blood to diagnose toxicity, guides treatment, and evaluates patients with neurological symptoms.
Test Parameters: 1. Manganese (Blood)
Pretest Condition: No fasting required. Collect whole blood, serum, or plasma. Report history of neurological symptoms or manganese exposure.
Specimen: Whole Blood (EDTA, 2-5 mL), Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document neurological symptoms, tremors, fatigue, or history of manganese exposure. Include current medications, especially chelating agents.
Consent: Written consent required, detailing the tests purpose, manganese toxicity implications, and risks of blood collection.
Procedural Considerations: Uses toxicology methods (e.g., inductively coupled plasma mass spectrometry) to measure manganese in blood. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for manganese toxicity diagnosis.
Factors Affecting Result Accuracy: Contamination, hemolysis, or improper sample storage can affect results. Insufficient sample volume may reduce accuracy.
Clinical Significance: Elevated blood manganese confirms toxicity, guiding chelation therapy or environmental intervention. Normal levels may require further exposure assessment.
Specialist Consultation: Consult a toxicologist or neurologist for result interpretation and treatment planning.
Additional Supporting Tests: Urinary manganese levels, neurological assessment, or MRI to confirm manganese toxicity diagnosis.
Test Limitations: Blood manganese reflects recent and chronic exposure but may miss low-level exposure. Clinical correlation is needed.
References: CDC Toxic Metal Guidelines, 2023; Environmental Health Perspectives, Lucchini RG, 2022.
